Evidence map›Paper›PMID 42368484›Full record

ArticleCase reports in infectious diseases2026

Suspected Macrolide-Refractory

Mohamed M G Mohamed, Garry Francis Morel, Matthew Stack, John Salomone, Ariel Rischall, Ghassan Kamel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Suspected Macrolide-RefractoryCase reports in infectious diseases · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed M G MohamedDivision of Pulmonary, Critical Care, & Sleep Medicine, Internal Medicine Department, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0000-0002-7514-7811
Garry Francis MorelDivision of Pulmonary, Critical Care, & Sleep Medicine, Internal Medicine Department, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0000-0001-9270-6315
Matthew StackDivision of Infectious Diseases, Allergy and Immunology, Internal Medicine Department, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0009-0005-5585-1675
John SalomoneDivision of Infectious Diseases, Allergy and Immunology, Internal Medicine Department, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0009-0008-2970-4841
Ariel RischallDivision of Hematology and Medical Oncology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0000-0001-7364-9116
Ghassan KamelDivision of Pulmonary, Critical Care, & Sleep Medicine, Internal Medicine Department, Saint Louis University School of Medicine, Saint Louis, Missouri, USA, slu.edu.ORCID https://orcid.org/0000-0002-9728-1851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suspected macrolide-refractory

Indexed as

case reportcoccidioidomycosisfalse-positive serologyhypogammaglobulinemiaimmunocompromised hostMycoplasma pneumoniaesuspected macrolide-refractory disease

Identifiers

PMID42368484
PMCPMC13309674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.